Product Description:-
 
Lenvima, also known by its generic name Lenvatinib, is a prescription medication used in the treatment of certain types of cancer. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) that work by targeting and inhibiting specific proteins involved in the growth and spread of cancer cells. Lenvatinib is primarily used in the treatment of thyroid cancer and kidney cancer.
Uses:
Differentiated Thyroid Cancer (DTC): Lenvima is indicated for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC). This includes cases where the cancer has spread to other parts of the body and is no longer responsive to radioactive iodine treatment.Renal Cell Carcinoma (RCC): Lenvima, in combination with the medication everolimus, is indicated for the treatment of advanced renal cell carcinoma (kidney cancer) after prior anti-angiogenic therapy has been unsuccessful. This is typically used when other treatments have not effectively controlled the progression of the cancer.
Side Effect:
• Hypertension (high blood pressure)• Fatigue or weakness• Diarrhea• Nausea or vomiting• Loss of appetite• Weight loss• Proteinuria (protein in the urine)• Hand-foot syndrome (redness, swelling, and pain on palms and soles)• Abdominal pain• Headache• Joint or muscle pain• Changes in taste
Dosages:
Differentiated Thyroid Cancer (DTC):The typical starting dosage for DTC is 24 mg (two 10 mg capsules plus one 4 mg capsule) taken orally once daily.Dosage adjustments may be made based on your individual response and any side effects you experience.Renal Cell Carcinoma (RCC) in Combination with Everolimus:The recommended dosage for RCC, when used in combination with everolimus, is typically 18 mg (two 10 mg capsules plus one 8 mg capsule) taken orally once daily.Dosage adjustments may be necessary based on your response and any adverse effects.
FAQs:
1. What is Lenvima?Ans. Lenvima is a prescription medication used in the treatment of certain types of cancer, including differentiated thyroid cancer and renal cell carcinoma.
2.How does Lenvima work?Ans. Lenvima is a tyrosine kinase inhibitor that works by targeting specific enzymes involved in the growth and spread of cancer cells. It helps inhibit the formation of blood vessels that supply nutrients to tumors, slowing down their growth.
3. What types of cancer is Lenvima used to treat?Ans. Lenvima is used to treat locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC) and advanced renal cell carcinoma (RCC) after prior anti-angiogenic therapy.
4. How is Lenvima taken?Ans. Lenvima is taken orally in capsule form. The dosage and administration instructions will be provided by your healthcare provider based on your specific condition.